Novavax Makes Big Move Donating 1.1 Billions Doses to Serum Institute of India as part of COVAX Deal
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to […]
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to […]
The Drugs Controller General of India (DCGI) issued emergency authorization for two vaccines, including ‘COVISHIELD’, produced by the Serum Institute […]
TrialSite reported on Nov. 30 that a volunteer participating in the ‘Covishield’ COVID-19 vaccine study in India sued the vaccine […]
A nonprofit scientific research organization known as IAVI, dedicated to addressing urgent unmet global health challenges, has spent years in […]
Adar Poonawalla leads perhaps the busiest vaccine production operation in the world. The billionaire and CEO of Serum Institute of India (SII) […]
The Serum Institute of India (SII) recently partnered up with AstraZeneca and Oxford University to progress COVID vaccine candidate AZD1222 […]
India’s Serum Institute of India, the world’s busiest vaccine manufacturer as measured by volume, emerges as a worldwide key player […]
Indian Council of Medical Research announced plans to conduct large-scale clinical trials of two TB vaccines including one developed in […]